SEC Form 4 · accession 0001144204-15-051971
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sunil Bhonsle
Officer — President · Director
Period of report
Aug 25, 2015
Accepted (ET)
Aug 26, 2015 · 2:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 25, 2015 | P | 50,000 | $0.696 | A | 481,500 | D | |
| Common StockF2 | holding | — | — | — | 300,757 | I | By Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.6799 to $0.70. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- F2The reporting person serves as trustee of the family trust.